U.S. Pregnancy Rapid Diagnostic Test Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2025-2034

U.S. pregnancy rapid diagnostic test market, valued at USD 371.1 million in 2024, is set to expand at a projected CAGR of 5.4% from 2025 to 2034. Growing consumer preference for quick, reliable, and convenient pregnancy detection solutions is fueling market growth. Increased awareness about reproductive health and advancements in diagnostic technology are driving demand for both home-based and clinical testing options. The introduction of highly sensitive tests capable of detecting human chorionic gonadotropin (hCG) even before a missed period has strengthened market adoption.

Continuous innovation in rapid diagnostics has enabled the development of more accurate and faster-reacting tests, offering enhanced reliability. Digital advancements, including smart features that integrate with mobile apps, are also contributing to the expanding market. The rise in fertility treatments and early pregnancy monitoring has further intensified the need for ultra-sensitive tests. With growing accessibility through retail and online channels, pregnancy rapid diagnostic tests are becoming an essential tool for early pregnancy confirmation.

The midstream test stick segment is witnessing steady expansion, with a projected CAGR of 5.6% during the forecast period. These tests are preferred for their ease of use, mess-free application, and fast results, typically within one to three minutes. Their high sensitivity allows for early pregnancy detection, making them a favored option among consumers seeking quick and accurate confirmation. The integration of smart features, including Bluetooth connectivity and digital tracking, is improving the overall testing experience.

The demand for 10 mIU/mL sensitivity pregnancy rapid diagnostic tests is also increasing, with the segment expected to grow at a CAGR of 5.5% through 2034. These highly sensitive tests detect pregnancy four to six days before a missed period, making them particularly valuable for individuals closely monitoring conception or undergoing fertility treatments. Their ability to identify very low hCG levels makes them a reliable choice for those with irregular menstrual cycles or those requiring early confirmation for timely medical guidance. The rising preference for digital pregnancy tests and fertility tracking solutions is further supporting market growth.

Retail pharmacies in the U.S. are playing a key role in market expansion, with this segment projected to grow at a CAGR of 5.2% over the forecast period. Consumers benefit from the availability of various pregnancy test formats, including strips, cassettes, and midstream sticks, all approved by regulatory authorities. Pharmacies offer the advantage of professional guidance, ensuring individuals select the most suitable option based on their needs.

The homecare segment is on a strong growth trajectory, set to expand at a CAGR of 5.6% through 2034. The demand for private, convenient, and easy-to-use pregnancy tests is driving the popularity of at-home testing kits. Over-the-counter availability and user-friendly designs have simplified the process, eliminating the need for medical supervision. Advances in digital pregnancy tests featuring smart connectivity allow users to track results in real time, further boosting consumer confidence in at-home testing solutions. The increasing emphasis on reproductive health awareness is also contributing to market growth.